Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
Liver fibrosis, which is characterized by the excessive deposition of extracellular matrix (ECM) materials (primarily fibrillar collagen-I), is an abnormal repair reaction and pathological outcome of chronic liver diseases caused by alcohol abuse, non-alcoholic fatty liver disease, and chronic hepat...
Saved in:
Main Authors: | Le Li (Author), Zhijun Zhu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ferroptosis as an emerging therapeutic target in liver diseases
by: Yuzhen Lu, et al.
Published: (2023) -
Therapeutic effects of natural compounds against diabetic complications via targeted modulation of ferroptosis
by: Zhen Zhang, et al.
Published: (2024) -
Post-Translational Modifications of p53 in Ferroptosis: Novel Pharmacological Targets for Cancer Therapy
by: Le Zhang, et al.
Published: (2022) -
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway
by: Lenan Xu, et al.
Published: (2023) -
Targeting Ferroptosis Attenuates Interstitial Inflammation and Kidney Fibrosis
by: Lu Zhou, et al.
Published: (2021)